Studies of imipramine binding to human serum albumin by high-performance affinity chromatography

Michelle J. Yoo, Quentin R. Smith, David S Hage

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Binding by the drug imipramine to the protein human serum albumin (HSA) was studied by using high-performance affinity chromatography. The association equilibrium constants and number of binding sites for imipramine with HSA were first estimated by utilizing frontal analysis. Imipramine was found to have one major binding site on HSA with an association equilibrium constant of 1.6 × 105 M-1 at pH 7.4 and 37 °C, as well as a second group of weaker and non-specific binding regions (8-9 mol/mol HSA) with an average association equilibrium constant of 1.5 × 103 M-1. Competition studies based on zonal elution were performed to identify the location of the major binding site for imipramine on HSA. Imipramine was found to have direct competition with L-tryptophan, which indicated that imipramine was interacting with Sudlow site II, or the indole-benzodiazepine site of HSA. No competition or allosteric effects were noted between imipramine and warfarin, a probe for Sudlow site I or the warfarin-azapropazone site of HSA. The association equilibrium constant found for imipramine at its site of competition with L-tryptophan also agreed with the value that was obtained for the major binding site of imipramine in the frontal analysis studies. These results confirmed that Sudlow site II was the location of the major binding site for imipramine on HSA. These results gave good agreement with previous observations made in the literature and should provide a more detailed description of how imipramine is transported in blood and of how it may interact with other drugs in the body.

Original languageEnglish (US)
Pages (from-to)1149-1154
Number of pages6
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume877
Issue number11-12
DOIs
StatePublished - Apr 15 2009

Fingerprint

Affinity chromatography
Imipramine
Affinity Chromatography
Serum Albumin
Equilibrium constants
Binding Sites
Association reactions
Warfarin
Tryptophan
Apazone
Benzodiazepines
Pharmaceutical Preparations
Blood

Keywords

  • Competition studies
  • Frontal affinity chromatography
  • High-performance affinity chromatography
  • Human serum albumin
  • Imipramine
  • Protein binding

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

Studies of imipramine binding to human serum albumin by high-performance affinity chromatography. / Yoo, Michelle J.; Smith, Quentin R.; Hage, David S.

In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, No. 11-12, 15.04.2009, p. 1149-1154.

Research output: Contribution to journalArticle

@article{06b3a190934e4083af2764580e3531c1,
title = "Studies of imipramine binding to human serum albumin by high-performance affinity chromatography",
abstract = "Binding by the drug imipramine to the protein human serum albumin (HSA) was studied by using high-performance affinity chromatography. The association equilibrium constants and number of binding sites for imipramine with HSA were first estimated by utilizing frontal analysis. Imipramine was found to have one major binding site on HSA with an association equilibrium constant of 1.6 × 105 M-1 at pH 7.4 and 37 °C, as well as a second group of weaker and non-specific binding regions (8-9 mol/mol HSA) with an average association equilibrium constant of 1.5 × 103 M-1. Competition studies based on zonal elution were performed to identify the location of the major binding site for imipramine on HSA. Imipramine was found to have direct competition with L-tryptophan, which indicated that imipramine was interacting with Sudlow site II, or the indole-benzodiazepine site of HSA. No competition or allosteric effects were noted between imipramine and warfarin, a probe for Sudlow site I or the warfarin-azapropazone site of HSA. The association equilibrium constant found for imipramine at its site of competition with L-tryptophan also agreed with the value that was obtained for the major binding site of imipramine in the frontal analysis studies. These results confirmed that Sudlow site II was the location of the major binding site for imipramine on HSA. These results gave good agreement with previous observations made in the literature and should provide a more detailed description of how imipramine is transported in blood and of how it may interact with other drugs in the body.",
keywords = "Competition studies, Frontal affinity chromatography, High-performance affinity chromatography, Human serum albumin, Imipramine, Protein binding",
author = "Yoo, {Michelle J.} and Smith, {Quentin R.} and Hage, {David S}",
year = "2009",
month = "4",
day = "15",
doi = "10.1016/j.jchromb.2009.02.070",
language = "English (US)",
volume = "877",
pages = "1149--1154",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "11-12",

}

TY - JOUR

T1 - Studies of imipramine binding to human serum albumin by high-performance affinity chromatography

AU - Yoo, Michelle J.

AU - Smith, Quentin R.

AU - Hage, David S

PY - 2009/4/15

Y1 - 2009/4/15

N2 - Binding by the drug imipramine to the protein human serum albumin (HSA) was studied by using high-performance affinity chromatography. The association equilibrium constants and number of binding sites for imipramine with HSA were first estimated by utilizing frontal analysis. Imipramine was found to have one major binding site on HSA with an association equilibrium constant of 1.6 × 105 M-1 at pH 7.4 and 37 °C, as well as a second group of weaker and non-specific binding regions (8-9 mol/mol HSA) with an average association equilibrium constant of 1.5 × 103 M-1. Competition studies based on zonal elution were performed to identify the location of the major binding site for imipramine on HSA. Imipramine was found to have direct competition with L-tryptophan, which indicated that imipramine was interacting with Sudlow site II, or the indole-benzodiazepine site of HSA. No competition or allosteric effects were noted between imipramine and warfarin, a probe for Sudlow site I or the warfarin-azapropazone site of HSA. The association equilibrium constant found for imipramine at its site of competition with L-tryptophan also agreed with the value that was obtained for the major binding site of imipramine in the frontal analysis studies. These results confirmed that Sudlow site II was the location of the major binding site for imipramine on HSA. These results gave good agreement with previous observations made in the literature and should provide a more detailed description of how imipramine is transported in blood and of how it may interact with other drugs in the body.

AB - Binding by the drug imipramine to the protein human serum albumin (HSA) was studied by using high-performance affinity chromatography. The association equilibrium constants and number of binding sites for imipramine with HSA were first estimated by utilizing frontal analysis. Imipramine was found to have one major binding site on HSA with an association equilibrium constant of 1.6 × 105 M-1 at pH 7.4 and 37 °C, as well as a second group of weaker and non-specific binding regions (8-9 mol/mol HSA) with an average association equilibrium constant of 1.5 × 103 M-1. Competition studies based on zonal elution were performed to identify the location of the major binding site for imipramine on HSA. Imipramine was found to have direct competition with L-tryptophan, which indicated that imipramine was interacting with Sudlow site II, or the indole-benzodiazepine site of HSA. No competition or allosteric effects were noted between imipramine and warfarin, a probe for Sudlow site I or the warfarin-azapropazone site of HSA. The association equilibrium constant found for imipramine at its site of competition with L-tryptophan also agreed with the value that was obtained for the major binding site of imipramine in the frontal analysis studies. These results confirmed that Sudlow site II was the location of the major binding site for imipramine on HSA. These results gave good agreement with previous observations made in the literature and should provide a more detailed description of how imipramine is transported in blood and of how it may interact with other drugs in the body.

KW - Competition studies

KW - Frontal affinity chromatography

KW - High-performance affinity chromatography

KW - Human serum albumin

KW - Imipramine

KW - Protein binding

UR - http://www.scopus.com/inward/record.url?scp=63249110856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63249110856&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2009.02.070

DO - 10.1016/j.jchromb.2009.02.070

M3 - Article

VL - 877

SP - 1149

EP - 1154

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 11-12

ER -